ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026

NMDA subunit 2B-selective negative allosteric modulator satoprodil (BI 1569912) as mono- and adjunctive therapy in patients with major depressive disorder: results from two phase 2 randomized, controlled trials.

Elan A Cohen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.